GGrantIndex
← Leaderboards

Fred Hutchinson Cancer Center

Seattle, WA

Compare ↔
$1,577,693,966
Total funding
745
Grants

Funding over time

peak $480.9M · FY2008–25
$500M$375M$250M$125M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,497,494,765 · 704
DOD$65,517,934 · 35
FDA$5,598,533 · 2
USDA$4,969,948 · 1
NSF$3,483,081 · 5
DOE$2,104,287 · 1

By mechanism

UM1$664,129,776 · 7
R01$298,835,654 · 216
—$76,075,249 · 42
U01$62,513,351 · 31
U24$60,798,413 · 6
N01$54,521,881 · 5

Investigators at Fred Hutchinson Cancer Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Christopher W Peterson$4,927,7513 gr2Jennifer Eileen Adair$3,353,8452 gr3Guang-Shing Cheng$3,067,6111 gr4Hamideh Parhiz$2,983,6723 gr5Jim Boonyaratanakornkit$2,338,2061 gr6Meghan Anne Koch$2,049,2821 gr7Maria Lemos$1,777,1371 gr8Melody G Campbell$1,760,0001 gr

Emerging Leaders

6–10 yrs in

1Geoffrey Roger Hill$7,017,2662 gr2Kevin Jon Cheung$4,402,6572 gr3Cyrus M Ghajar$4,356,4052 gr4Lev Silberstein$2,477,9301 gr5Yunda Huang$1,777,1371 gr6Marie Pancera$1,286,4472 gr7Adam James Isabella$714,6311 gr

All-Time

Most funded here, all years

1Hans-Peter Kiem$40,106,10722 gr2Denise A. Galloway$25,269,9597 gr3Stephen J. Tapscott$24,660,4788 gr4Leonidas A Stamatatos$22,740,7439 gr5Stanley R Riddell$19,446,8536 gr6Barry L. Stoddard$18,138,77210 gr7Toshio Tsukiyama$17,612,2144 gr8Dan H. Barouch$16,119,3589 gr

Largest grants

CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern$55,953,346
UM1 · FY2022 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center$38,851,667
UM1 · FY2023 · AI
HIV Vaccine Trials Network Laboratory Center$38,409,483
UM1 · FY2023 · AI
SDMC: HIV Vaccine Trials Network$35,817,302
UM1 · FY2025 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center$34,194,667
UM1 · FY2022 · AI
SDMC: HIV Vaccine Trials Network$31,992,488
UM1 · FY2024 · AI
HIV Vaccine Trials Network Laboratory Center$30,868,345
UM1 · FY2022 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center$30,396,659
UM1 · FY2025 · AI
HIV Vaccine Trials Network Laboratory Center$30,362,486
UM1 · FY2025 · AI
HIV Vaccine Trials Network Laboratory Center$28,707,507
UM1 · FY2024 · AI
SDMC: HIV Vaccine Trials Network$28,510,098
UM1 · FY2023 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center$21,949,062
UM1 · FY2024 · AI
SDMC: HIV Vaccine Trials Network$21,460,272
UM1 · FY2022 · AI
SDMC: HIV Prevention Trials Network$20,886,260
UM1 · FY2024 · AI
SDMC: HIV Prevention Trials Network$19,992,286
UM1 · FY2025 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern$19,404,520
UM1 · FY2023 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center$17,943,267
UM1 · FY2022 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern$14,844,618
UM1 · FY2022 · AI
SDMC: HIV Prevention Trials Network$14,385,924
UM1 · FY2023 · AI
CoVPN 3008 2022-2023$12,647,369
UM1 · FY2023 · AI